| Product Code: ETC7539510 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell and Gene Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell and Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell and Gene Therapy Market - Industry Life Cycle |
3.4 India Cell and Gene Therapy Market - Porter's Five Forces |
3.5 India Cell and Gene Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 India Cell and Gene Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Cell and Gene Therapy Market Revenues & Volume Share, By Delivery Mode, 2021 & 2031F |
3.8 India Cell and Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Cell and Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in India |
4.2.2 Growing investments in research and development of cell and gene therapies |
4.2.3 Favorable government initiatives and policies supporting the adoption of advanced therapies |
4.3 Market Restraints |
4.3.1 High treatment costs associated with cell and gene therapies |
4.3.2 Limited awareness and understanding of cell and gene therapies among healthcare providers and patients in India |
5 India Cell and Gene Therapy Market Trends |
6 India Cell and Gene Therapy Market, By Types |
6.1 India Cell and Gene Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 India Cell and Gene Therapy Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 India Cell and Gene Therapy Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 India Cell and Gene Therapy Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 India Cell and Gene Therapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Cell and Gene Therapy Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.3 India Cell and Gene Therapy Market Revenues & Volume, By Oncology Disorder, 2021- 2031F |
6.2.4 India Cell and Gene Therapy Market Revenues & Volume, By Genetic Disorder, 2021- 2031F |
6.2.5 India Cell and Gene Therapy Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.2.6 India Cell and Gene Therapy Market Revenues & Volume, By Neurological Disorder, 2021- 2031F |
6.2.7 India Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Cell and Gene Therapy Market, By Delivery Mode |
6.3.1 Overview and Analysis |
6.3.2 India Cell and Gene Therapy Market Revenues & Volume, By In-Vivo, 2021- 2031F |
6.3.3 India Cell and Gene Therapy Market Revenues & Volume, By Ex-Vivo, 2021- 2031F |
6.4 India Cell and Gene Therapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Cell and Gene Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Cell and Gene Therapy Market Revenues & Volume, By Cancer Care Centers, 2021- 2031F |
6.4.4 India Cell and Gene Therapy Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.5 India Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 India Cell and Gene Therapy Market Import-Export Trade Statistics |
7.1 India Cell and Gene Therapy Market Export to Major Countries |
7.2 India Cell and Gene Therapy Market Imports from Major Countries |
8 India Cell and Gene Therapy Market Key Performance Indicators |
8.1 Patient outcomes and treatment efficacy rates |
8.2 Number of clinical trials and research collaborations in the cell and gene therapy sector |
8.3 Adoption rates of cell and gene therapies in different regions of India |
9 India Cell and Gene Therapy Market - Opportunity Assessment |
9.1 India Cell and Gene Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 India Cell and Gene Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Cell and Gene Therapy Market Opportunity Assessment, By Delivery Mode, 2021 & 2031F |
9.4 India Cell and Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Cell and Gene Therapy Market - Competitive Landscape |
10.1 India Cell and Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Cell and Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here